Zobrazeno 1 - 6
of 6
pro vyhledávání: '"HIROHITO NOGUCHI"'
Autor:
Hirohito Noguchi, Erina Hasegawa, Kaede Sato, Hiroko Abe, Miyu Munakata, Aya Ueki, Kazuki Ohashi, Toshiaki Yoshida, Michitaka Imai, Mitsuyuki Suzuki, Miki Kobayashi, Asami Hoshii, Fujiko Koyama, Hiroshi Hirosawa, Shiori Hirosawa, Tomomi Nakano, Toru Ishikawa
Publikováno v:
European Journal of Gastroenterology & Hepatology. 31:1408-1413
AIM This study aimed to clarify the relationship between pre-sarcopenia (PS) and quality of life (QOL) in patients with chronic liver disease (CLD). PATIENTS AND METHODS This cross-sectional study evaluated 335 patients with CLD. PS was diagnosed on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5aa93bf018947c58a2cd98e9086f1e6
https://doi.org/10.1097/meg.0000000000001415
https://doi.org/10.1097/meg.0000000000001415
Autor:
Toshiaki Yoshida, Asami Hoshii, Kazuki Ohashi, Yuta Mitobe, Toru Ishikawa, Michitaka Imai, Hirohito Noguchi, Tamaki Hokari, Hiroshi Hirosawa, Mitsuyuki Suzuki
Publikováno v:
Journal of Clinical Medicine
Volume 10
Issue 7
Journal of Clinical Medicine, Vol 10, Iss 1419, p 1419 (2021)
Volume 10
Issue 7
Journal of Clinical Medicine, Vol 10, Iss 1419, p 1419 (2021)
Although dual-energy X-ray absorptiometry (DXA) and body impedance analysis are commonly used to measure skeletal muscle mass (SMM), a computed tomography (CT) scan is preferred in clinical practice. We aimed to propose the cut-off values of skeletal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a14285131b271884326aa6c28b0beeb8
http://europepmc.org/articles/PMC8036892
http://europepmc.org/articles/PMC8036892
Autor:
Mitsuyuki Suzuki, Yu Koyama, Asami Hoshii, Yuta Mitobe, Yuko Kikuchi, Hiroshi Hirosawa, Hirohito Noguchi, Hansani Madushika Abeywickrama, Etsuko Yamada, Tamaki Hokari, Toru Ishikawa, Kazuki Ohashi
Publikováno v:
Journal of Clinical Medicine Research
Background: Sarcopenia is a prognostic factor for patients with liver cirrhosis and hepatocellular carcinoma, and it affects the onset of hepatic encephalopathy. Therefore, the prevention of sarcopenia contributes to the improvement of the prognosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f1c4504caf1e2c220944e663d95dfe8
https://pubmed.ncbi.nlm.nih.gov/31636786
https://pubmed.ncbi.nlm.nih.gov/31636786
Autor:
Fujiko Koyama, Hiroshi Hirosawa, Ai Sakuma, Miki Kobayashi, Satoshi Abe, Shiori Yamagata, Toru Ishikawa, Mitsuyuki Suzuki, Tomomi Nakano, Kazutaka Ohashi, Erina Hasegawa, Hiroko Abe, Aya Ueki, Yuka Maruyama, Hirohito Noguchi, Toshiaki Yoshida, Takako Fukazawa
Publikováno v:
Experimental and Therapeutic Medicine. 12:3353-3358
The rate of sustained virologic response (SVR) has increased in patients with chronic hepatitis C (CHC; genotype 1) since triple treatment with pegylated interferon (PEG-IFN), ribavirin (RBV) and telaprevir (TVR) was included in Japanese health insur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a1946fe333dcaa282970e502e334266
https://doi.org/10.3892/etm.2016.3785
https://doi.org/10.3892/etm.2016.3785
Autor:
Toshiaki Yoshida, Toru Ishikawa, Tomomi Nakano, Takako Fukazawa, Mitsuyuki Suzuki, Fujiko Koyama, Hiroshi Hirosawa, Yuka Maruyama, Hirohito Noguchi, Aya Ueki, Miki Kobayashi, Hiroko Abe, Shiori Hirosawa, Kazuki Ohashi, Erina Hasegawa, Kaede Sato
Publikováno v:
Experimental and therapeutic medicine. 15(1)
Interferon-free direct acting antiviral agent regimens for chronic hepatitis C (CHC) have been developed. These regimens have shown a high rate of sustained virologic response (SVR), and a reduction in side effects during treatment is also anticipate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e3a680cc4088ffbdaae22b96e24d89f
https://pubmed.ncbi.nlm.nih.gov/29399105
https://pubmed.ncbi.nlm.nih.gov/29399105
Autor:
MITSUYUKI SUZUKI, TORU ISHIKAWA, AI SAKUMA, SATOSHI ABE, HIROKO ABE, FUJIKO KOYAMA, TOMOMI NAKANO, AYA UEKI, HIROHITO NOGUCHI, ERINA HASEGAWA, SHIORI YAMAGATA, MIKI KOBAYASHI, KAZUTAKA OHASHI, HIROSHI HIROSAWA, TAKAKO FUKAZAWA, YUKA MARUYAMA, TOSHIAKI YOSHIDA
Publikováno v:
Experimental & Therapeutic Medicine; Nov2016, Vol. 12 Issue 5, p3353-3358, 6p